These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Physiologic evaluation in the elderly prior to treatment with chemotherapy. Hallek M Clin Adv Hematol Oncol; 2007 Aug; 5(8):620-1. PubMed ID: 17982402 [No Abstract] [Full Text] [Related]
4. Is response rate relevant to the phase II trial design of targeted agents? Dowlati A; Fu P J Clin Oncol; 2008 Mar; 26(8):1204-5. PubMed ID: 18285601 [No Abstract] [Full Text] [Related]
5. Influence of measurement error on response rates. Warr D; McKinney S; Tannock I Cancer Treat Rep; 1985 Oct; 69(10):1127-32. PubMed ID: 4042092 [No Abstract] [Full Text] [Related]
6. Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? Simone CB; Simone CB J Natl Cancer Inst; 2008 Nov; 100(21):1558-9; author reply 1559-1560. PubMed ID: 18957669 [No Abstract] [Full Text] [Related]
7. Reflections on medical oncology: 25 years of clinical trials--where have we come and where are we going? Booth CM; Tannock I J Clin Oncol; 2008 Jan; 26(1):6-8. PubMed ID: 18165630 [No Abstract] [Full Text] [Related]
9. Combinations go on trial. Delude C Cancer Discov; 2012 Jan; 2(1):8. PubMed ID: 22585151 [No Abstract] [Full Text] [Related]
10. [Role of growth factors in development of preeclampsia]. Stoĭkova V; Ivanov S; Tsoncheva A Akush Ginekol (Sofiia); 2007; 46(7):24-6. PubMed ID: 18333417 [No Abstract] [Full Text] [Related]
11. Ghrelin: a novel peptide with therapeutic effect in certain cancers? Aydin S; Geckil H; Karaoglu A; Elkiran ET Med Hypotheses; 2007; 69(5):1157-8. PubMed ID: 17445993 [No Abstract] [Full Text] [Related]
12. [An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors]. Lang A; Graeven U Zentralbl Chir; 2009 Jun; 134(3):189-92. PubMed ID: 19544236 [No Abstract] [Full Text] [Related]
13. Bevacizumab: new indication. Metastatic breast cancer: many adverse effects. Prescrire Int; 2008 Dec; 17(98):236. PubMed ID: 19422148 [No Abstract] [Full Text] [Related]
14. [Current topics of chemotherapy for sarcoma and bone neoplasms]. Hirata T; Ando M Gan To Kagaku Ryoho; 2008 Mar; 35(3):415-419. PubMed ID: 18401919 [No Abstract] [Full Text] [Related]
15. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer]. Tamura K Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020 [No Abstract] [Full Text] [Related]
16. Bevacizumab in kidney cancer: new indication. Premature approval of this indication. Prescrire Int; 2009 Feb; 18(99):10. PubMed ID: 19382401 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for clinical stage I nonseminomatous germ cell tumours. Vaughn DJ BJU Int; 2009 Nov; 104(9 Pt B):1381-6. PubMed ID: 19840017 [No Abstract] [Full Text] [Related]
19. Second-line chemotherapy in head and neck cancer: what should we expect? Büntzel J; Micke O Expert Rev Anticancer Ther; 2009 Mar; 9(3):269-73. PubMed ID: 19275504 [No Abstract] [Full Text] [Related]